India Region Formulations Cis

Rediff.com » News » India Region Formulations Cis

News for India Region Formulations Cis

Business

Exports up 17.25% in Oct; highest in over 2 years

India's merchandise exports in October rose by an impressive 17.25 per cent year-on-year, highest in over two years, to $39.2 billion, while the trade deficit widened to $27.14 billion on a......

Pharma MNCs' pills make Indian rivals sick

Indian pharmaceutical companies have tried to defend their turf through aggressive pricing for long. They are now getting a taste of the same medicine from Big Pharma.Pharma multinationals are......

Glenmark Pharma net dips 31 percent

A sharp increase in interest costs has caused Glenmark Pharmaceuticals to post a consolidated net profit of Rs 80.9 crore for the second quarter, 31 percent lower than the Rs 117.3 crore for the......

Pharma majors shift slect production to India

After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddy's Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to......

Ranbaxy buys Terapia for $324 million

India's leading drug-maker Ranbaxy on Wednesday said it has acquired Terapia, the largest independent generic company in Romania, for $324 million and aims to make that country its manufacturing......

Rediff News

India Region Formulations Cis

News for India Region Formulations Cis

Exports up 17.25% in Oct; highest in over 2 years

Pharma MNCs' pills make Indian rivals sick

Glenmark Pharma net dips 31 percent

Pharma majors shift slect production to India

Ranbaxy buys Terapia for $324 million

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS